Arena Pharmaceuticals (ARNA) 10-K2017 FY Annual report

Filed: 14 Mar 18, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: accused, adding, alkaline, analog, Asian, attorney, auditor, BBA, beneficiary, bill, binding, Bipartisan, Cadillac, circumvent, Concurrent, Concurrently, confidence, customary, deconsolidated, deconsolidation, Deferral, diagnostic, discipline, distance, divest, divested, divestiture, donut, double, employed, endoscopic, Everest, excise, exhaustive, expansion, exploratory, extenuating, Fitch, flat, gap, GDPR, Hallucination, heightened, hepatic, hole, Hong, inquiry, insignificant, judged, Kong, light, Macau, mainland, marker, Moody, motivate, neurologic, neurological, numerical, offshore, onset, owed, PCAOB, percent, Pharma, phosphatase, precede, predisposing, preserve, proliferating, proliferation, PVR, repatriated, resolution, Secretary, split, subordinated, temporary, tentative, top, topline, Trump, unavailable, unclear, underwriting, underwritten, unduly, unrealized, unsatisfied, VAS, Venezuela, walk

Removed: alternate, APIC, capitalize, comprised, constitute, continuation, COSO, doubt, equally, GreTai, imminent, IMS, indemnification, indirect, inflation, inspect, instrument, labor, liquidation, lymph, machinery, Ministry, MOH, overhead, peripheral, planned, presumption, prostanoid, realizable, routine, smoking, TaiGen, utilize, volume, windfall

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

Associated ARNA transcripts

ARNA similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 10.44

Arena Pharmaceuticals, Inc.

Summary of Housing Allowance for Vincent E. Aurentz

On January 19, 2018, the Compensation Committee of the Board of Directors of Arena Pharmaceuticals, Inc. (“Arena”) approved a housing allowance for Vincent Aurentz, Arena’s Executive Vice President and Chief Business Officer, from February 2018 through February 2019 in the amount of $7,000.00 per month. The Compensation Committee also approved the reimbursement, on an after-tax basis, of Mr. Aurentz’s airfare between North Carolina and San Diego during this same time period.